Search research articles
Contact Us
Filters
Showing results (21-30 of 423) with videos related to
Page
of 43
Sort By:
Current Opinion in Pharmacology
|
February 11, 2012
Antibiotics as immunomodulant agents in COPD
Francesco Blasi, Marco Mantero, Stefano Aliberti
Biomedicines
|
July 29, 2025
Endotypes and Phenotypes in ILD: Is It Time to Reclassify ILD by Risk Stratification?
Francesco Amati, Anna Stainer, Stefano Aliberti
European Journal of Internal Medicine
|
July 8, 2014
Dyspnea in crackling lungs
Luca Novelli, Stefano Aliberti, Alberto Pesci
International Journal of Nanomedicine
|
January 22, 2008
Clinical applications of azithromycin microspheres in respiratory tract infections
Francesco Blasi, Stefano Aliberti, Paolo Tarsia
European Journal of Internal Medicine
|
June 26, 2012
The role of lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia
Angelika Reissig, Andrea Gramegna, Stefano Aliberti
The European Respiratory Journal
|
November 6, 2025
Emerging therapies in bronchiectasis
Oriol Sibila, Lidia Perea, Stefano Aliberti
Respiration; International Review of Thoracic Diseases
|
March 9, 2005
Strategic targets of essential host-pathogen interactions
Francesco Blasi, Paolo Tarsia, Stefano Aliberti
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 31, 2012
Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores
Stefano Aliberti, Anna Maria Zanaboni, Francesco Blasi
The European Respiratory Journal
|
March 21, 2015
Management of bronchiectasis in adults
James D Chalmers, Stefano Aliberti, Francesco Blasi
The European Respiratory Journal
|
March 1, 2023
A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet
Mattia Nigro, James D Chalmers, Stefano Aliberti
Page
of 43
Search research articles
Search
Showing results (21-30 of 423) with videos related to
Sort By:
Page
of 43
Current Opinion in Pharmacology
|
February 11, 2012
Antibiotics as immunomodulant agents in COPD
Francesco Blasi, Marco Mantero, Stefano Aliberti
Biomedicines
|
July 29, 2025
Endotypes and Phenotypes in ILD: Is It Time to Reclassify ILD by Risk Stratification?
Francesco Amati, Anna Stainer, Stefano Aliberti
European Journal of Internal Medicine
|
July 8, 2014
Dyspnea in crackling lungs
Luca Novelli, Stefano Aliberti, Alberto Pesci
International Journal of Nanomedicine
|
January 22, 2008
Clinical applications of azithromycin microspheres in respiratory tract infections
Francesco Blasi, Stefano Aliberti, Paolo Tarsia
European Journal of Internal Medicine
|
June 26, 2012
The role of lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia
Angelika Reissig, Andrea Gramegna, Stefano Aliberti
The European Respiratory Journal
|
November 6, 2025
Emerging therapies in bronchiectasis
Oriol Sibila, Lidia Perea, Stefano Aliberti
Respiration; International Review of Thoracic Diseases
|
March 9, 2005
Strategic targets of essential host-pathogen interactions
Francesco Blasi, Paolo Tarsia, Stefano Aliberti
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 31, 2012
Pneumonia in the community caused by multidrug-resistant organisms: keep working on probabilistic scores
Stefano Aliberti, Anna Maria Zanaboni, Francesco Blasi
The European Respiratory Journal
|
March 21, 2015
Management of bronchiectasis in adults
James D Chalmers, Stefano Aliberti, Francesco Blasi
The European Respiratory Journal
|
March 1, 2023
A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet
Mattia Nigro, James D Chalmers, Stefano Aliberti
Page
of 43